Stereotaxis STXS
NYSE STXS
$1.30 -0.02 (-1.52%)
As of: Sep 10, 2026 · 3:59 PM EDT

Stereotaxis (STXS) Operating Income (2010 - 2026)

Stereotaxis' (STXS) quarterly Operating Income came in at -$6.0 million in Q1 2026, down 0.88% year-over-year from -$6.0 million in Q1 2025, and down 5.88% quarter-over-quarter from -$5.6 million in Q4 2025.

Analysis

Stereotaxis (STXS) Operating Income (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Operating Income for 17 consecutive years, with -$6.0 million the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Operating Income fell 0.88% year-over-year to -$6.0 million in Q1 2026; TTM through Mar 2026 was -$22.2 million, a 14.5% increase from a year earlier, with the FY2025 full-year figure at -$22.1 million, up 10.62% from the prior year.
  • Operating Income was -$6.0 million for Q1 2026 at Stereotaxis, down from -$5.6 million in the prior quarter.
  • Over five years, Operating Income peaked at -$4.0 million in Q2 2025 and troughed at -$7.6 million in Q4 2024.
  • A 5-year average of -$5.5 million and a median of -$5.6 million in 2023 frame the typical range for Operating Income.
  • Across the five-year window, Operating Income plunged 167.6% in 2022 and jumped 33.95% in 2025, its largest moves.
  • Over 5 years, Operating Income stood at -$4.5 million in 2022, then declined by 19.03% to -$5.3 million in 2023, then plunged by 43.8% to -$7.6 million in 2024, then advanced by 25.93% to -$5.6 million in 2025, then decreased by 5.88% to -$6.0 million in 2026.
  • The last three Operating Income figures came in at -$6.0 million (Q1 2026), -$5.6 million (Q4 2025), and -$6.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 1.69 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 971.90 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 1.76 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 1.66 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 1.18 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 513.20 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 11.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 318.30 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 285.80 Mn
10 Stereotaxis 129.55 Mn 114.93 Mn 3.79 Mn -5.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.98 Mn
Dec 31, 2025 -5.65 Mn
Sep 30, 2025 -6.56 Mn
Jun 30, 2025 -3.98 Mn
Mar 31, 2025 -5.93 Mn
Dec 31, 2024 -7.63 Mn
Sep 30, 2024 -6.35 Mn
Jun 30, 2024 -6.02 Mn
Mar 31, 2024 -4.75 Mn
Dec 31, 2023 -5.30 Mn
Sep 30, 2023 -5.64 Mn
Jun 30, 2023 -5.28 Mn
Mar 31, 2023 -5.62 Mn
Dec 31, 2022 -4.46 Mn
Sep 30, 2022 -5.05 Mn
Jun 30, 2022 -5.18 Mn
Mar 31, 2022 -4.09 Mn
Dec 31, 2021 -3.35 Mn
Sep 30, 2021 -4.62 Mn
Jun 30, 2021 -3.39 Mn